- Business
- NutryFarm International Limited (SGX: AZT) is an investment holding company engaged in the research, development, manufacturing, sale, and marketing of nutrition and health food products formulated from natural traditional medicinal herbs. The company operates through three main segments: Nutrition, Health Food, and Related Health Products, which produces and sells nutrition supplements, health foods, and related wellness items; Internet Management, which provides technical support services for Internet and web-television businesses; and Investment Holding, which manages available-for-sale investments, financial instruments, and treasury operations. Its core offerings include high-quality nutrition and health food products developed through its subsidiary NutryFarm Biomedicine International Limited, targeting health-conscious consumers with herbal-based supplements.
Geographically, NutryFarm International Limited maintains operations primarily in Asia, with a focus on Singapore, Hong Kong, and China, serving retail, healthcare, and enterprise customers. Founded in 1986 and headquartered at Star House, 19th Floor, Room 1916, 3 Salisbury Road, Tsim Sha Tsui, Hong Kong, the company, formerly known as Lottvision Ltd., has a wholly-owned subsidiary in NutryFarm (Chengdu) for production.
In recent developments, the company's subsidiary AI Nova Pte Ltd launched a new business segment in October 2025 focused on high-performance computing, data center operations, and telecommunication services, including cloud-based computing supply agreements backed by corporate guarantees. Additionally, AI Nova Sdn Bhd entered a memorandum of understanding with Asas Panorama Sdn Bhd for strategic partnerships. In December 2025, NutryFarm completed an independent review by FTI Consulting Singapore, as directed by the Singapore Exchange, on proposed acquisitions of First Linkage Inc. and Xinjiang Zhongtong Internet Science and Technology Development Co., Ltd., alongside prepayments and advances to related parties, amid ongoing judicial management and SGX-flagged corporate governance issues including late disclosures and unexplained loans totaling over HKD59.8 million owed by parties like Wang Xiaoxin.